We believe the world is changing faster than ever

Join a Two Sigma Ventures portfolio company to help shape the future of technology.
Leverage our network to build your career.
Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Senior Manager Corporate Development and Data Strategy



San Francisco, CA, USA
Posted on Saturday, May 13, 2023

The Opportunity

insitro is changing the way that drugs are discovered and developed for patients by applying a machine learning-driven approach that leverages insights derived from a combination of external human cohort data and high-quality cellular data generated in-house. To enable and execute on this vision, we require access to large and/or deep datasets with high-content phenotypic measurements relevant to human health. We need to be nimble, thoughtful, and creative in prioritizing, accessing, and/or creating these datasets, as well as in how to best leverage the data and our platform to maximally benefit patients.

The Senior Manager of Corporate Development and Data Strategy will be responsible for collaborating with internal scientific and technical teams to prioritize external engagements that enable access to a generation of high-content clinical and molecular data critical for the development of insitro’s platform. Reporting to the Senior Director of Corporate Development and Head of Data Strategy, you will contribute to insitro’s larger scientific and corporate strategy by supporting the identification, structuring, and execution of diverse collaboration structures focused on expanding our footprint across human genetic and clinical data. This is an excellent opportunity for someone passionate about therapeutic discovery and making an impact to patients!

Your key responsibilities will include the following:

  • Working cross-functionally to scope, negotiate and execute innovative transactions centered on human data, machine learning, and their joint application to improve clinical outcomes
  • Landscaping available data sources and modalities to align with the needs and capabilities of insitro's ML and TA teams
  • Creatively structure collaborations and identify “win-win” opportunities with potential partners
  • Communicate effectively and collaborate cross-functionally to coordinate input into partnering strategy and execution
  • Supporting additional corporate development activities, including asset diligence and biopharma collaborations, as necessary

You will be joining an exciting biotech startup that has long-term stability due to significant funding, while maintaining a culture of innovation. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and impact on patient outcomes. Join us, and help make a difference to patients!

About You

  • Undergraduate degree in biology, biochemistry, bioinformatics, genetics, computer science or statistics (with bio/clinical data focus) or related field
  • 4+ years of professional experience, with one or more of:
    • Business development and/or client-facing function at a provider of genetic, genomic, proteomic, transcriptomic and/or tissue data generation technology for translational science or clinical development
    • Strategy consulting with project experience oriented towards use of human data for discovery, health tech / data platforms, and/or providers of R&D or translational science technologies (e.g., sequencing, imaging, etc.)
    • Investment banking focused on discovery stage biotech and/or R&D or translational science technology companies
  • Strong understanding of high-content human data modalities (e.g., genetics/genomics, histopathological imaging, spatial biology) and data generation technologies
  • Familiarity with computational methods that are relevant to biomedical informatics, clinical informatics, statistical genetics, and/or medical genetics
  • A bias to action and ability to operate effectively under ambiguous, rapidly changing circumstances
  • Passion for building something different and desire to make a difference in the world

Nice to Have

  • Exposure to the research and development stages of the pharmaceutical value chain, including target discovery, target validation, and clinical trials
  • Experience working under the resource and time constraints of an early stage startup
  • Advanced degree (PhD or MD) in computational biology, genetics/genomics, biomedical / clinical informatics, machine learning (with focus on clinical data), or equivalent experience in the diagnostics, data, or biopharma industry

Compensation & Benefits at insitro

Our target starting salary for successful US-based applicants for this role is $190,000 - $215,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data. This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
  • 401(k) plan with employer matching for contributions
  • Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees), as well as mental health and well-being support
  • Open, flexible vacation policy
  • Paid parental leave
  • Quarterly budget for books and online courses for self-development
  • Support to occasionally attend professional conferences that are meaningful to your career growth and development
  • New hire stipend for home office setup
  • Monthly cell phone & internet stipend
  • Access to free onsite baristas and cafe with daily lunch and breakfast
  • Access to free onsite fitness center
  • Commuter benefits
About insitro
insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience, oncology and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.